Patient-derived GBM cells expressing shRNAs for either VEGF or NRP1 show reduced stemness markers and neurosphere-forming capacity, and knockdown of VEGF and NRP1 inhibits the growth of patient-derived GBM xenografts in both zebrafish and mice and prolongs mouse survival. Here, NRP1 is linked to glioblastoma.